Estados Unidos - inglés - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. triazolam is contraindicated in: - patients with known hypersensitivity to triazolam, any of component of triazolam tablets, or other benzodiazepines. reactions consistent with angioedema (involving the tongue, glottis, or larynx), dyspnea, and throat closing have been reported and may be fatal. - concomitant administration of strong cytochrome p450 (cyp 3a) enzyme inhibitors (e.g., ketoconazole, itraconazole, nefazodone, lopinavir, ritonavir) [ see warnings and precautions ( 5.8 ), drug interactions ( 7.1) ] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including triazolam, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pre

Canadá - inglés - Health Canada

pro doc limitee - triazolam - tablet - .125mg - triazolam .125mg - benzodiazepines

Canadá - inglés - Health Canada

pro doc limitee - triazolam - tablet - .25mg - triazolam .25mg - benzodiazepines

Canadá - inglés - Health Canada

prempharm inc - triazolam - tablet - 0.125mg - triazolam 0.125mg - benzodiazepines

Canadá - inglés - Health Canada

prempharm inc - triazolam - tablet - 0.25mg - triazolam 0.25mg - benzodiazepines

Canadá - inglés - Health Canada

mylan pharmaceuticals ulc - triazolam - tablet - 0.125mg - triazolam 0.125mg - benzodiazepines

Canadá - inglés - Health Canada

mylan pharmaceuticals ulc - triazolam - tablet - 0.25mg - triazolam 0.25mg - benzodiazepines

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

kyowa pharmaceutical industry co., ltd - triazolam - pale purple tablet, major axis: approx. 8.0mm, minor axis: approx. 5.6mm, thickness: approx. 2.2mm

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

kyowa pharmaceutical industry co., ltd - triazolam - pale blue tablet, major axis: approx. 8.0mm, minor axis: approx. 5.6mm, thickness: approx. 2.2mm

Estados Unidos - inglés - NLM (National Library of Medicine)

pharmacia & upjohn company llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. halcion is contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including halcion, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/ risk summary neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.10) and ]. available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see ) . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pr